Skip to main content
Earnings Labs
CorMedix Inc. logo

CorMedix Inc. (CRMD)

NASDAQ·Healthcare·Biotechnology

$7.50

-0.73%

Mkt Cap $590.74M

Analyst Ratings

Buy

7

Hold

0

Sell

0

Price Target (8 analysts)

$13.50

Range $13.00$14.00

Implied Upside

+80.1%

Consensus $13.50 vs current $7.50